3Dainel A, Thierry N, Marie FL, et al. Novel genentic structure associated with an extended-spectrum β-lactamase blaVEB gene in a Providencia stuartii clinical isolate from Algeria[J]. J Antimi crob Agents Chemother, 2005,49 (8) : 3590-3592.
4Lee HW, Kang HY, Shin KS, et al. Multidrug-resistant Providencia isolates carrying blaPER-1, blaVIM-2, and armA[J]. J Microbiol,2007,45(3) :272-274.
5National Committee for Clinical Laboratory Standards. Perform anee standards for antimicrobial disk susceptibility tests [S]. M100-S9. NCCLS,1999.32-36.
6Pitout JDD, Reisbig MD, Venter EC, et al. Modification of double-disk test for detection of Enterobacteriaceae producing extended-spectrum and ampC β-lactamases[J]. J Clin Micro biol, 2003,41(8) :3933-3935.
7Shiroto K, Ishii Y, Kimura S, et al. Metallo-beta-lactamase IMP-1 in Providencia rettgeri from two different hospitals in Japan[J]. J Med Microbiol,2005,54(11) :1065-1070.
8Nagano N, Nagano Y, Cordevant C, et al. Nosocomial transmission of CTX-M-2 β-lactamase-producing Acinetobacter baumannii in a neurosurgery ward[J]. J Clin Microbiol,2004,42 (9) : 3978 - 3984.
9Munday C J, Whitehead G M. Todd N J. et al. Predominance and genetic diversity of community and hospital acquired CTXM extended spectrum β-lactamases in York, UK[J]. J Antimicrob Chemother. 2004.54(3) : 628 - 633.
10Munday C j. Xiong J, Li C. Dissemination of CTX-M type β- lactamases in Enterobacteriaceae isolates in the People's Republic of China[J]. Int. J Antimicrob Agents.2004.23(2): 175 - 180.
